Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 2
Submit an article Journal homepage
2,427
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Zebularine protects against blood-brain-barrier (BBB) disruption through increasing the expression of zona occludens-1 (ZO-1) and vascular endothelial (VE)-cadherin

Xiangliang Zenga Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Guohua Heb Department of Neurology, The affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha 410004, Hunan Province, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0900-3112View further author information
ORCID Icon,
Xirong Yanga Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Guoyao Xua Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Yidan Tanga Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Hanwen Lia Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Bing Yua Department of Neurology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua City, 418000, Hunan Province, ChinaView further author information
,
Zhen Wangb Department of Neurology, The affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha 410004, Hunan Province, ChinaView further author information
,
Wei Xub Department of Neurology, The affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha 410004, Hunan Province, ChinaView further author information
&
Kangping Songb Department of Neurology, The affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha 410004, Hunan Province, ChinaView further author information
 show all
Pages 4441-4454 | Received 31 Oct 2021, Accepted 24 Dec 2021, Published online: 03 Feb 2022

References

  • Randolph SA. Ischemic stroke. Workplace Health Saf. 2016;64(9):444.
  • Cao Q, Yang F, Zhang J, et al. Features of childhood arterial ischemic stroke in China. Fetal Pediatr Pathol. 2019;38(4):317–325.
  • Wang D, Duan H, Feng J, et al. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction. Theranostics. 2020;10(1):231–246.
  • Tuttolomondo A, Puleo MG, Velardo MC, et al. Molecular biology of atherosclerotic ischemic strokes. Int J Mol Sci. 2020;21(24):9372.
  • Li Y, Zhu ZY, Lu BW, et al. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke. CNS Neurosci Ther. 2019;25(12):1343–1352.
  • Obermeier B, Verma A, Ransohoff RM. The blood-brain barrier. Handb Clin Neurol. 2016;133:39–59.
  • Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002;200(6):629–638.
  • Nahirney PC, Reeson P, Brown CE. Ultrastructural analysis of blood-brain barrier breakdown in the peri-infarct zone in young adult and aged mice. J Cereb Blood Flow Metab. 2016;36(2):413–425.
  • Liu J, Weaver J, Jin X, et al. Nitric oxide interacts with Caveolin-1 to facilitate autophagy-lysosome-mediated Claudin-5 degradation in oxygen-glucose deprivation-treated endothelial cells. Mol Neurobiol. 2016;53(9):5935–5947.
  • Zhao YJ, Nai Y, Li SY, et al. Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats. Eur Rev Med Pharmacol Sci. 2018;22(23):8509–8518.
  • Sass P, Sosnowski P, Podolak-Popinigis J, et al. Epigenetic inhibitor zebularine activates ear pinna wound closure in the mouse. EBioMedicine. 2019;46:317–329.
  • Lemaire M, Momparler LF, Raynal NJ, et al. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2ʹ-deoxycytidine. Cancer Chemother Pharmacol. 2009;63(3):411–416.
  • Cheng JC, Matsen CB, Gonzales FA, et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst. 2003;95(5):399–409.
  • Dock H, Theodorsson A, Theodorsson E. DNA methylation inhibitor zebularine confers stroke protection in ischemic rats. Transl Stroke Res. 2015;6(4):296–300.
  • Chiang T, Messing RO, Chou WH. Mouse model of middle cerebral artery occlusion. J Vis Exp. 2011;48.
  • Nong AN, Li QF, Huang ZJ, et al. MicroRNA miR-126 attenuates brain injury in septic rats via NF-κB signaling pathway. Bioengineered. 2021;12(1):2639–2648.
  • Cai LX, Li WF, Zeng RQ, et al. Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice. Bioengineered. 2021;12(1):9070–9080.
  • Rousselet E, Kriz J, Seidah NG. Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining. J Vis Exp. 2012 69;(69). DOI:10.3791/4038.
  • Dai LY, Jie SS, Bi SH, et al. Angiopoietin-2 silence alleviates lipopolysaccharide-induced inflammation, barrier dysfunction and endoplasmic reticulum stress of intestinal epithelial cells by blocking Notch signaling pathway. Bioengineered. 2021;12(1):8116–8124.
  • Yu AS, McCarthy KM, Francis SA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol. 2005;288(6):C1231–41.
  • Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium in Stroke. Circ Res. 2016;119(1):142–158.
  • Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res. 2009;77(1):53–63.
  • Pan J, Qu M, Li Y, et al. MicroRNA-126-3p/-5p overexpression attenuates blood-brain barrier disruption in a mouse model of middle cerebral artery occlusion. Stroke. 2020;51(2):619–627.
  • Rahmani MR, Shamsizadeh A, Moghadam-Ahmadi A, et al. Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke. Life Sci. 2018;198:143–148.
  • Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–2137.
  • Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–731.
  • Lei C, Zhang S, Cao T, et al. HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage. Neuroscience. 2015;295:39–47.
  • Hao Q, Su H, Palmer D, et al. Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9. Stroke. 2011;42(2):453–458.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.